Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

iwMyeloma 2023 | The future of myeloma therapy

In this session, Keith Stewart, MBChB, MRCP, FRCPC, MBA, Princess Margaret Cancer Centre, Toronto, Canada, Brian Walker, PhD, Indiana University School of Medicine, Indianapolis, IN, Martin Kortüm, MD, University Hospital Würzburg, Würzburg, Germany, and Claudia Stege, MD, PhD, Amsterdam UMC, Amsterdam, Netherlands, have a fascinating discussion about the future of myeloma therapy, covering topics including challenges in performing translational studies, imaging modalities to prevent disease progression, incorporating frailty in clinical trial designs, and individualizing therapy. This session was filmed at the 16th International Workshop on Multiple Myeloma (iwMyeloma) held in Madrid, Spain.